Integrating Non-Viral Gene Therapy and 3D Bioprinting for Bone, Cartilage and Osteochondral Tissue Engineering

The repair of osteochondral defects, affecting both the articular cartilage and the underlying subchondral bone, is key for the effective recovery of joint homeostasis and the prevention of further cartilage degeneration and the onset of osteoarthritis (OA). Although important advances have been made in the field of tissue engineering to regenerate these injuries, the traditional approaches based on the formation of homogenous tissues fail to recapitulate the spatial complexity of the osteochondral unit. The objective of this thesis was to engineer a multiphasic tissue suitable for osteochondral defect regeneration by combining 3D bioprinting and non-viral gene delivery to spatially regulate the differentiation of mesenchymal stem cells (MSCs). Realising this objective first required (1) optimisation of the non-viral gene delivery vector, (2) the identification of suitable therapeutic gene combinations to direct MSC differentiation and (3) the development of printable biomaterials, also known as bioinks, which were supportive of non-viral gene delivery both in vitro and in vivo. These gene activated bioinks were capable of spatially directing MSC fate towards either the osteogenic or chondrogenic pathway. In turn, this enabled the printing of mechanically robust biphasic osteochondral constructs with zonally confined gene delivery and spatially defined stem cell differentiation and matrix deposition. In vivo, these printed constructs promoted the development of tissue mimicking key aspects of the osteochondral unit. In conclusion, this thesis highlights a promising and novel approach for the incorporation of gene delivery for 3D bioprinting ande engineering of therapeutically relevant and structurally complex musculoskeletal tissues.

Year	Entry
2007	Oest ME, Dupont KM, Kong H, Mooney DJ, Guldberg RE. Quantitative assessment of scaffold and growth factor‐mediated repair of critically sized bone defects. J Orthop Res. July 2007;25(7):941-950.
2004	McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell. April 2004;6(4):483-495.
1998	Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg. December 1998;80A(12):1745-1757.
2003	Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post‐natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. April 2003;88(5):873-884.
2004	Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone. August 2004;35(2):562-569.
2006	Pelttari K, Winter A, Steck E, Goetzke K, Hennig T, Ochs BG, Aigner T, Richter W. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum. October 2006;54(10):3254-3266.
1982	Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. August 1982;30(1):215-224.
2001	Barry F, Boynton RE, Liu B, Murphy JM. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res. August 15, 2001;268(2):189-200.
2005	Ateshian GA, Mow VC. Friction, lubrication, and wear of articular cartilage and diarthrodial joints. In: Mow VC, Huiskes R, eds. Basic Orthopaedic Biomechanics & Mechano-Biology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:447-494.
2002	Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore MS, Ma YL, Nold JB. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol. May 1, 2002;30(3):312-321.
2013	Boskey AL. Bone composition: relationship to bone fragility and antiosteoporotic drug effects. BoneKEy Rep. December 2013;2:447.
2011	Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. June 18, 2011;377(9783):2115-2126.
2002	Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RAD, Filvaroff EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA. July 23, 2002;99(15):9656-9661.
1998	Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. Winter, 1998;4(4):415-428.
2001	Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods. December 2001;25(4):402-408.
2006	Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. January 2006;54(1):226-229.
1998	Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. January 10, 1998;238(1):265-272.
1994	Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. NEJM. October 6, 1994;331(14):889-895.

Year

Entry

2007

Oest ME, Dupont KM, Kong H, Mooney DJ, Guldberg RE. Quantitative assessment of scaffold and growth factor‐mediated repair of critically sized bone defects. J Orthop Res. July 2007;25(7):941-950.

2004

McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell. April 2004;6(4):483-495.

1998

Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg. December 1998;80A(12):1745-1757.

2003

Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post‐natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. April 2003;88(5):873-884.

2004

Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone. August 2004;35(2):562-569.